Robert Bindert Huizinga Aurinia Pharmaceuticals Inc. (AUPH) insider trading activity
Robert Bindert Huizinga is EVP of Research of Aurinia Pharmaceuticals Inc.. Currently has a direct ownership of 69,379 shares of AUPH, which is worth approximately $626,492. The most recent transaction as insider was on Mar 02, 2022, when has been sold 4,849 shares (Common Stock) at a price of $12.01 per share, resulting in proceeds of $58,236. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
69.4K
0%
3M change
0%
12M change
Total Value Held
$626,492
Robert Bindert Huizinga Transaction History
RBH
Robert Bindert Huizinga
EVP of Research
Victoria, A1